Coronary artery bypass graf is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
The key factors contributing to the coronary artery bypass graft devices market are the rising prevalence of cardiovascular disorders, increasing geriatric population base coupled and growing need for repeat revascularization procedure.

The global Coronary Artery Bypass Graft Devices market was valued at US$ 13670 million in 2020 and is expected to reach US$ 14630 million by the end of 2027, growing at a CAGR of 1.0% during 2021-2027.
This report focuses on Coronary Artery Bypass Graft Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Coronary Artery Bypass Graft Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Coronary Artery Bypass Graft Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Single CABG Surgery
Double CABG Surgery
Triple CABG Surgery
Quadruple CABG Surgery

Segment by Application
Medical Application
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Heratport
Medtronic
Guidant
Terumo
Maquet
Sorin
Abbott
Edward Life Sciences
Boston Scientific
Thoratec
Articure
Teleflex Medicals
Biosense Webster